Reuters logo
BRIEF-Aethlon Medical Receives expedited access pathway designation from FDA
September 12, 2017 / 11:38 AM / 3 months ago

BRIEF-Aethlon Medical Receives expedited access pathway designation from FDA

Sept 12 (Reuters) - Aethlon Medical Inc:

* Aethlon Medical receives expedited access pathway designation from FDA to accelerate U.S. access to the hemopurifier as a treatment for life-threatening viruses Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below